港股异动 | 希慎兴业(0014.HK)续涨近4% 绩后获多家机构看好
格隆汇8月11日丨昨日午后拉升并最终收涨2%的希慎兴业(0014.HK)今日续涨,现报23.85港元,涨3.92%,暂成交5094万港元,最新总市值248亿港元。希慎兴业昨日午间公布,上半年公司拥有人应占亏损26.26亿港元,而上年同期为盈利27.83亿港元;每股基本亏损252港仙,宣派第一次中期股息每股27港仙。绩后花旗发研报指,集团收入及持续利润均符该行预期,由于租务季节性因素,集团历史上于上半年表现都较高,维持“买入”评级,目标价37.4港元。大和亦指,希慎在困难时期中业绩表现具韧性,可能逐渐被视为专业管理的房地产投资信托基金,重申其买入评级及目标价48.6港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.